InsidersTradesSigma
Total declarations
Company
▲ Purchases (7 ops.)
▼ Sales (15 ops.)
Insider track record
Board DirectorDisclosed buys
7
Disclosed sells
15
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Dougan Brady W, Director. Director active across 1 company, notably Humacyte, Inc.. Aggregated, 26 disclosures have been logged. Breakdown: 7 buys · 15 sells. Total volume traded: €47.9m. Activity tracked since 14 December 2021. The latest transaction was filed on 19 November 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations26 total
1,797 shares@ US$4.440.0% of flowCommon StockSEC:0001818382-24-000213:0
Ideal exit: 16 Aug 2025 (T+270)
811,172 shares@ US$4.447.1% of flowCommon StockSEC:0001818382-24-000206:0
157,704 shares@ US$5.421.6% of flowCommon StockSEC:0001818382-24-000185:0
1,222 shares@ US$6.5450.0% of flowCommon StockSEC:0001818382-24-000175:0
Ideal exit: 26 May 2025 (T+270)
252,676 shares@ US$6.713.2% of flowCommon StockSEC:0001818382-24-000167:0
282,000 shares@ US$7.09223.9% of flowCommon StockSEC:0001818382-24-000100:0
2,362 shares@ US$6.350.0% of flowCommon StockSEC:0001818382-24-000086:0
Ideal exit: 1 Mar 2025 (T+270)
716,573 shares@ US$7.7810.7% of flowCommon StockSEC:0001818382-24-000083:0
2,050 shares@ US$7.370.0% of flowCommon StockSEC:0001818382-24-000075:0
Ideal exit: 28 Feb 2025 (T+270)
114,420 shares@ US$1.190.3% of flowCommon StockSEC:0001818382-23-000154:0
2,000,000 shares@ US$2.7810.9% of flowCommon StockSEC:0001818382-23-000129:0
570,174 shares@ US$3.684.0% of flowCommon StockSEC:0001818382-23-000120:0
500,000 shares@ US$3.11753.0% of flowCommon StockSEC:0001818382-23-000082:0
4,875,000 shares@ US$2.6024.4% of flowCommon StockSEC:0001818382-23-000048:0
2,625,000 shares@ US$2.7514.0% of flowCommon StockSEC:0001104659-23-065544:0
100,000 shares@ US$1.190.2% of flowCommon StockSEC:0001818382-23-000004:0
239,538 shares@ US$2.531.2% of flowCommon StockSEC:0001818382-22-000220:0
10,000 shares@ US$2.540.0% of flowCommon StockSEC:0001818382-22-000222:0
Ideal exit: 11 Sept 2023 (T+270)
330,000 shares@ US$2.841.8% of flowCommon StockSEC:0001818382-22-000210:0
1,522,500 shares@ US$4.0012.7% of flowCommon StockSEC:0001818382-22-000160:0
2,000 shares@ US$4.140.0% of flowCommon StockSEC:0001818382-22-000166:0
Ideal exit: 12 Jun 2023 (T+270)
10,000 shares@ US$4.839.9% of flowCommon StockSEC:0001818382-22-000051:0
Ideal exit: 17 Feb 2023 (T+270)
23,694 shares@ US$9.7980.4% of flowCommon StockSEC:0001104659-21-150679
23,694 shares@ US$9.79845.0% of flowCommon StockSEC:0001104659-21-150679:0
1,148,240 sharesCommon StockSEC:0001104659-21-110543:0
25 of 26 declarations
About Dougan Brady W
Dougan Brady W is a Board Member at Humacyte, Inc. He brings valuable expertise in corporate governance and strategy. In his role, he participates in overseeing the company's activities and making strategic decisions. Brady strives to ensure that the company adheres to ethical and regulatory standards while pursuing its growth objectives.
